Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Injunction Means Switches Have “Consequences,” Prosecutor Says

Executive Summary

The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences

You may also be interested in...



PBM Disclosure Requirements On Rx Switches Likely To Increase Costs – FTC

Pharmaceutical benefit manager disclosure requirements related to drug switches are likely to increase consumers' drug costs rather than strengthen consumer protections, the Federal Trade Commission said in its review of PBM transparency legislation under consideration in California

PBM Disclosure Requirements On Rx Switches Likely To Increase Costs – FTC

Pharmaceutical benefit manager disclosure requirements related to drug switches are likely to increase consumers' drug costs rather than strengthen consumer protections, the Federal Trade Commission said in its review of PBM transparency legislation under consideration in California

Medco Contract With AIG Shows That “Transparency” Pays Off, PBM Says

Medco's contract with AIG shows that "transparency" can offer a competitive advantage in the pharmacy benefit management sector, Medco CEO David Snow maintained during the Banc of America Securities conference in Las Vegas May 20

Related Content

UsernamePublicRestriction

Register

PS043978

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel